Immunoglobulin A Nephropathy (IgAN)
6 clinical trials · Condition
◉ Watch Immunoglobulin A Nephropathy (IgAN)
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Effect of ARGX-121 on the Change in Proteinuria in Adult Participants With IgAN (NCT07773727) | argenx | 2026-10-15 |
| Chinese Adults With Kidney Disease (NCT07522099) | ADARx Pharmaceuticals, Inc. | 2026-05-21 |
| A Study to Assess the Effects of Zigakibart on IgA Nephropathy. (NCT07146906) | Novartis Pharmaceuticals | 2026-03-26 |
| Efficacy and Safety Study of HS-10542 for IgA Nephropathy (NCT07474636) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2026-03-17 |
| A Study of Cizutamig in Patients With Immunoglobulin A Nephropathy (NCT07135219) | Peking University First Hospital | 2025-07-16 |
| A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN) (NCT06935357) | Biogen | 2025-05-08 |
Track Immunoglobulin A Nephropathy (IgAN) automatically
Every clearance here is in the API, with alerts when new ones post.